l carnitine concentrate L-Carnitine Oral Paste Liquid L-Carnitine 1000mg CoQ10 100mg

maintenance phase is the heavy draw 26 weeks 13 vials Standard Phase 2 duration 32 weeks 16 vials Phase 2 T2D study duration 68 weeks 30 vials REDEFINE 1 / REDEFINE 2 endpoint duration Peptide Vials (10 mg vial, 2.4 mg/week target) Each 10 mg vial covers about 4 weekly doses at 2.4 mg/week

and around the world

Deficiency symptoms in children include developmental delay, regression, irritability, involuntary movements, and hypotonia

Nutrition-rich formula with glutathione and niacinamide firms and brightens eye area

Some patients notice nothing yet during the ramp-up phase

138 The interaction between CST1 and GPX4 improves the stability of GPX4 protein and reduces the intracellular ROS, thus inhibiting ferroptosis